Literature DB >> 23971770

Sex differences between cT4b and pT4b rectal cancers.

Koji Komori1, Kenya Kimura, Takashi Kinoshita, Tsuyoshi Sano, Seiji Ito, Tetsuya Abe, Yoshiki Senda, Kazunari Misawa, Yuichi Ito, Norihisa Uemura, Yasuhiro Shimizu.   

Abstract

We retrospectively evaluated rectal cancer surgery cases in which resection had been performed for invasion of other organs in terms of pathologic findings from the viewpoint of sex differences. We enrolled 61 consecutive patients with rectal cancer who had undergone curative surgery with resection of invaded adjacent organs. We investigated invasion of adjacent organs in terms of pathologic findings according to sex differences. Among males, 4 cases (13.8%) had received combined radical resections of more than 2 organs, while the number of such female cases was 15 (46.9%). The difference between males and females was statistically significant (P = 0.006). Among male cases, histopathologic invasion was present in 4 (13.8%), while 9 female cases (28.1%) showed this feature. Nevertheless, there was not a statistically significant difference between males and females (P = 0.08); the rate in females was roughly twice that in males. No significant difference was recognized in the overall survival rates between males and females, but more females than males experienced local recurrence. In cases with rectal cancer invading neighboring organs, the effect of the invasion must be carefully determined, and the most appropriate operative approach selected accordingly.

Entities:  

Mesh:

Year:  2013        PMID: 23971770      PMCID: PMC3756839          DOI: 10.9738/INTSURG-D-13-00027.1

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  11 in total

1.  Pathology studies of combined radical resection of seminal vesicle in the treatment of rectal cancer.

Authors:  Koji Komori; Takashi Hirai; Yukihide Kanemitsu; Yasuhiro Shimizu; Tsuyoshi Sano; Seiji Ito; Yoshiki Senda; Kazunari Misawa; Yuichi Ito; Tomoyuki Kato
Journal:  Int Surg       Date:  2011 Jan-Mar

2.  Preliminary experience with bladder preservation for lower rectal cancers involving the lower urinary tract.

Authors:  Norio Saito; Takanori Suzuki; Toshiyuki Tanaka; Masanori Sugito; Masaaki Ito; Akihiro Kobayashi; Yusuke Nishizawa; Nozomi Minagawa; Yuji Nishizawa; Kazuhiro Watanabe
Journal:  J Surg Oncol       Date:  2010-12-01       Impact factor: 3.454

3.  Multivisceral resection for primary locally advanced rectal carcinoma.

Authors:  D A Harris; M Davies; M G Lucas; P Drew; N D Carr; J Beynon
Journal:  Br J Surg       Date:  2010-12-24       Impact factor: 6.939

4.  Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

Authors:  J Philip Kuebler; H Samuel Wieand; Michael J O'Connell; Roy E Smith; Linda H Colangelo; Greg Yothers; Nicholas J Petrelli; Michael P Findlay; Thomas E Seay; James N Atkins; John L Zapas; J Wendall Goodwin; Louis Fehrenbacher; Ramesh K Ramanathan; Barbara A Conley; Patrick J Flynn; Gamini Soori; Lauren K Colman; Edward A Levine; Keith S Lanier; Norman Wolmark
Journal:  J Clin Oncol       Date:  2007-04-30       Impact factor: 44.544

5.  Preoperative radio/chemo-radiotherapy in combination with intraoperative radiotherapy for T3-4Nx rectal cancer.

Authors:  S Sadahiro; T Suzuki; K Ishikawa; M Fukasawa; T Saguchi; S Yasuda; H Makuuchi; C Murayama; Y Ohizumi
Journal:  Eur J Surg Oncol       Date:  2004-09       Impact factor: 4.424

6.  Results of extended surgery for cancer of the rectum and sigmoid.

Authors:  G Bonfanti; F Bozzetti; R Doci; F Baticci; R Marolda; P Bignami; L Gennari
Journal:  Br J Surg       Date:  1982-06       Impact factor: 6.939

7.  Circumferential resection margin as a prognostic factor in rectal cancer.

Authors:  T E Bernstein; B H Endreseth; P Romundstad; A Wibe
Journal:  Br J Surg       Date:  2009-11       Impact factor: 6.939

8.  Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

Authors:  Thierry André; Corrado Boni; Lamia Mounedji-Boudiaf; Matilde Navarro; Josep Tabernero; Tamas Hickish; Clare Topham; Marta Zaninelli; Philip Clingan; John Bridgewater; Isabelle Tabah-Fisch; Aimery de Gramont
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

9.  Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision.

Authors:  P Quirke; P Durdey; M F Dixon; N S Williams
Journal:  Lancet       Date:  1986-11-01       Impact factor: 79.321

10.  Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer.

Authors:  Kazutaka Yamada; Takashi Ishizawa; Kiyoshi Niwa; Yutaka Chuman; Takashi Aikou
Journal:  Dis Colon Rectum       Date:  2002-08       Impact factor: 4.585

View more
  1 in total

1.  Gender differences in stage at diagnosis and preoperative radiotherapy in patients with rectal cancer.

Authors:  Cristina Sarasqueta; Mª Victoria Zunzunegui; José María Enríquez Navascues; Arrate Querejeta; Carlos Placer; Amaia Perales; Nerea Gonzalez; Urko Aguirre; Marisa Baré; Antonio Escobar; José María Quintana
Journal:  BMC Cancer       Date:  2020-08-14       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.